Your AI-Powered Market Intelligence

Monday, October 26, 2026
RSS

Analysis

Forward P/E vs Trailing P/E: Which One to Trust

Trailing P/E uses the last four quarters of reported GAAP earnings; forward P/E uses analyst estimates for a coming fiscal year. Eight large caps on the October 16, 2026 close show when the gap means growth and when it means distortion.

October 19, 2026
IPO
IPO
Trade with the conviction of the 1%.

Institutional-grade market intelligence delivered before the opening bell.

By subscribing, I agree to receive marketing emails and alerts. View our Privacy Policy. You may unsubscribe at any time.


Markets

VIX Breaks Above 22 as AI Stock Rout Raises Risk of More Market Volatility

The VIX climbed above 22 as AI-related stocks sold off, signaling wider swings and rising event risk…

Oct 17, 2026
Earnings

Kimberly-Clark’s Best Week in Four Years Puts Kenvue Deal in Focus

Kimberly-Clark’s strongest week in four years is shifting attention to Q3 developments and momentum …

Oct 17, 2026
Markets

CoreWeave’s Credit Signals Flash Warning as AI Infrastructure Sell-Off Deepens

CoreWeave’s falling stock and rising credit-market costs highlight a growing divide between equity p…

Oct 17, 2026
Economy

U.S. Industrial Production Surges 0.7%, Beating Estimates as Capacity Utilization Rises

Stronger U.S. industrial data may pressure Treasury yields and reshape rate expectations while testi…

Oct 16, 2026
Markets

Copart’s ACV Auctions Deal Changes the Online Vehicle-Marketplace Map

Copart’s completed ACV Auctions acquisition removes $ACVA as a standalone listing and gives $CPRT a …

Oct 16, 2026
Markets

Dow Surges 556 Points as CoreWeave Shock Triggers Rotation Away From AI Stocks

The Dow jumped 556 points as concerns over CoreWeave’s debt financing widened the gap between blue-c…

Oct 16, 2026
Markets

Proofpoint’s $6.3 Billion Varonis Deal Tests Cybersecurity M&A Appetite

Proofpoint’s $6.3 billion all-cash bid for Varonis puts the focus on VRNS holders, deal-arbitrage dy…

Oct 16, 2026
Markets

CCC Intelligent Solutions Set for $6.1 Billion Take-Private Deal Led by GTCR and Elliott

CCC Intelligent Solutions agreed to a $6.1 billion take-private deal led by GTCR and Elliott, highli…

Oct 15, 2026
Earnings

Labcorp’s BioReference Deal Is a Bet on Scale—and a Signal of Diagnostics Consolidation

Labcorp’s planned purchase of select BioReference assets for up to $872 million highlights consolida…

Oct 15, 2026